FDA SEEKING SHUT DOWN OF BARR LABS FOR GMP VIOLATIONS, UNAPPROVED MANUFACTURING CHANGES; COMPANY CLAIMS MOST OBSERVATIONS IN FDA 483 ARE "MISLEADING"